Vericel Reports Second Quarter 2019 Financial Results and Raises Full Year 2019 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Vericel (VCEL) Tops Q2 EPS by 41c, Revenue Beat; Raises FY19 Revenue Guidance
August 6, 2019 7:25 AM EDTVericel (NASDAQ: VCEL) reported Q2 EPS of ($0.05), $0.41 better than the analyst estimate of ($0.46). Revenue for the quarter came in at $26.2 million versus the consensus estimate of $24.12 million.
Second Quarter 2019 Financial Highlights
Total net product revenues increased 38% to $26.2 million compared to $19.0 million in the second quarter of 2018;Gross margin of 66% compared to gross margin of 59% in the second quarter of 2018;Net loss of $19.8 million, or $0.45 per share, which includes the $17.5 million upfront license payment to MediWound for North American rights to NexoBrid®;Non-GAAP adjusted net loss, excluding the $17.5 million... More